Advantage of First-Line Therapeutic Drug Monitoring-Driven Use of Infliximab for Treating Acute Intestinal and Liver GVHD in Children: A Prospective, Single-Center Study

SIMPLE SUMMARY: Acute GVHD is a common life-threatening complication of allogeneic HSCT and the second most common cause of death in allogeneic HSCT recipients following relapse of the primary disease. Despite advances in GVHD therapy, many patients do not respond sufficiently, and biomarkers to pre...

Descripción completa

Detalles Bibliográficos
Autores principales: Maximova, Natalia, Nisticò, Daniela, Riccio, Guglielmo, Maestro, Alessandra, Barbi, Egidio, Faganel Kotnik, Barbara, Marcuzzi, Annalisa, Rimondi, Erika, Di Paolo, Antonello
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376946/
https://www.ncbi.nlm.nih.gov/pubmed/37509268
http://dx.doi.org/10.3390/cancers15143605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10376946/
https://www.ncbi.nlm.nih.gov/pubmed/37509268
http://dx.doi.org/10.3390/cancers15143605

Ejemplares similares